Skip to main content

Table 2 Main clinical characteristics of the study subjects at December 31, 2013

From: Susceptibility to particle health effects, miRNA and exosomes: rationale and study protocol of the SPHERE study

Characteristics N  
BMI, Kg/cm2 1247 33.5 ± 5.5
BMI categorical   
<30 Kg/cm2   347 (27.8%)
30-35 Kg/cm2   483 (38.6%)
≥35 Kg/cm2   420 (33.6%)
Waist circumference, cm 1237 101.3 ± 13.1
Blood pressure, mmHg 1247  
Sistolic   125.4 ± 15.8
Diastolic   78.5 ± 9.5
Above 140/90 mmHg   60 (4.8%)
Below 140/90 mmHg   1190 (95.2%)
Heart rate, bpm 1243 67.6 ± 10.4
Uric acid 1163 5.2 ± 1.4
Fibrinogen, mg/dl 1129 335 ± 59
C-reactive protein 1160 0.3 [0.1-0.5]
Total cholesterol, mg/dl 1165 215.1 ± 41
HDL   59.2 ± 15.5
LDL   134.7 ± 36.3
Triglyceride 1164 107 [77–145.5]
Serum creatinine, mg/dL 1165 0.8 ± 0.3
AST, U/I 1159 19 [16–23]
ALT, U/I 1160 21 [16–30.5]
Gamma-Glutamyltransferase, IU/L 1162 19 [13–30]
Glucose 1155 92 [86–101]
Homocysteine 1151 10.4 [8.6–12.7]
TSH 1163 1.7 [1.2–2.5]
Glycated hemoglobin, mmol/mol 1159 39 [36.6–43]
Postprandial glycaemia, mg/dl 1162 99 [90–112]
Insulin level 1158 12.3 [8.8–18]
2-hour post glucose insulin level 1155 46.4 [27.6–73]
Urinary pH 1144 5.6 ± 0.7
Emocrome 1156  
  White blood cells   6.8 ± 1.7
  Red blood cells   4.8 ± 0.4
  Hemoglobin   13.8 ± 1.4
  Hematocrit   40.7 ± 3.4
  Mean Corpuscolar Volume   85.1 ± 6.4
  Platelets   249.7 ± 59
  1. Continuous variable are expressed as mean ± standard deviation (SD) or as median [first quartile-third quartile] if not normally distributed; discrete variables are expressed as counts (%).